E-LIB Suche - Ergebnisse für: Chabanon, Anne-Laure

1

Background incidence rates of health outcomes of interest f..:

Banga, Sonja ; Khromava, Alena ; Serradell, Laurence...
BMJ Open. 14 (2024) 7 - p. e083947 , 2024

Link: https://doi.org/10.1136/..

2

Enhanced passive safety surveillance of a quadrivalent inac..:

Syrkina, Olga ; Inamdar, Ajinkya ; Wague, Sophie...
BMC Public Health. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

Enhanced passive safety surveillance of the quadrivalent in..:

Chabanon, Anne-Laure ; Wague, Sophie ; Moureau, Annick..
BMC Public Health. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Enhanced passive safety surveillance of a trivalent and a q..:

Serradell, Laurence ; Wagué, Sophie ; Moureau, Annick..
Human Vaccines & Immunotherapeutics. 17 (2020) 4 - p. 1205-1210 , 2020

Link: https://doi.org/10.1080/..

5

Safety of a quadrivalent influenza vaccine in Vietnamese he..:

Thiem, Vu Dinh ; Chabanon, Anne-Laure ; Fournier, Marion...
Human Vaccines & Immunotherapeutics. 17 (2020) 3 - p. 690-693 , 2020

Link: https://doi.org/10.1080/..

6

Enhanced passive safety surveillance of three marketed infl..:

Gandhi-Banga, Sonja ; Chabanon, Anne-Laure ; Eymin, Cecile...
Human Vaccines & Immunotherapeutics. 15 (2019) 9 - p. 2154-2158 , 2019

Link: https://doi.org/10.1080/..

7

Immunogenicity and safety of a multi-dose quadrivalent inac..:

Ojeda, Joyce ; Arredondo, José Luis ; Salcedo, Perla...
Human Vaccines & Immunotherapeutics. 16 (2019) 6 - p. 1380-1384 , 2019

Link: https://doi.org/10.1080/..

8

Immunogenicity and safety of a quadrivalent inactivated inf..:

Vesikari, Timo ; Virta, Miia ; Heinonen, Seppo...
Human Vaccines & Immunotherapeutics. 16 (2019) 3 - p. 623-629 , 2019

Link: https://doi.org/10.1080/..

9

Passive enhanced safety surveillance for Vaxigrip and Intan..:

Bricout, Hélène ; Chabanon, Anne Laure ; Souverain, Audrey...
Eurosurveillance. 22 (2017) 18 - p. , 2017

Link: https://doi.org/10.2807/..

10

Report from enhanced safety surveillance of two influenza v..:

Chabanon, Anne Laure ; Bricout, Hélène ; Ballandras, Céline...
Human Vaccines & Immunotherapeutics. 14 (2017) 2 - p. 378-385 , 2017

Link: https://doi.org/10.1080/..

11

Immunogenicity and safety of a quadrivalent inactivated inf..:

Vesikari, Timo ; Virta, Miia ; Heinonen, Seppo...
2164-554X. , 2020

Link: https://trepo.tuni.fi/ha..

12

Immunogenicity and safety of a quadrivalent inactivated inf..:

Vesikari, Timo ; Virta, Miia ; Heinonen, Seppo...
10.1080/21645515.2019.1667202. , 2020

Link: http://hdl.handle.net/10..

13

Enhanced passive safety surveillance of a quadrivalent inac..:

Olga Syrkina ; Ajinkya Inamdar ; Sophie Wague...
https://doi.org/10.1186/s12889-022-13898-z. , 2022

Link: https://doi.org/10.1186/..

14

Safety of a quadrivalent influenza vaccine in Vietnamese he..:

Vu Dinh Thiem ; Anne-Laure Chabanon ; Marion Fournier...
http://dx.doi.org/10.1080/21645515.2020.1795477. , 2021

Link: https://doi.org/10.1080/..

15

Enhanced passive safety surveillance of a trivalent and a q..:

Laurence Serradell ; Sophie Wagué ; Annick Moureau..
http://dx.doi.org/10.1080/21645515.2020.1804247. , 2021

Link: https://doi.org/10.1080/..